ClassID:

117435

C12Y306/05 - CPC Classification

Classification description:

Hydrolases acting on acid anhydrides (3.6) acting on GTP; involved in cellular and subcellular movement (3.6.5)

Sub-classes:
Recent Application in this class:
#1
20260076906
2026-03-19

Nanoparticles for Enhancing Mitochondrial Networks

#2
20240344041
2024-10-17

ARTIFICIAL PROTEIN TO RESTORE SYNAPTIC FUNCTION

#3
20240074416
2024-03-07

Rat models for CMT2A that develop a progressive neuropathy

#4
20230270884
2023-08-31

COMPOSITIONS USEFUL FOR TREATMENT OF CHARCOT-MARIE-TOOTH DISEASE

#5
20230242960
2023-08-03

MUTANTS OF A FILAMENTOUS FUNGAL CELL HAVING INCREASED PRODUCTIVITY IN THE PRODUCTION OF A POLYPEPTIDE

#6
20210330756
2021-10-28

Acetylation of Miro1

#7
20200054718
2020-02-20

EGFR/MFN2 Targeted Nanoparticles Particularly Useful For Treating Multidrug Resistant Triple Negative Breast Cancer Through Mitochondrial Fusion Inhibition

#8
20200053991
2020-02-20

Rat models for CMT2A that develop a progressive neuropathy

#9
20190374628
2019-12-12

MUTATED FRAGMENTS OF THE RAS PROTEIN

#10
20180080926
2018-03-22

Peptide regulators of mitochondrial fusion and methods of use

#11
20180036385
2018-02-08

AAV-mediated gene therapy for RPGR X-linked retinal degeneration

#12
20170320964
2017-11-09

Modulators of ACYL-COA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof

#13
20170283852
2017-10-05

Ubiquitination system and the uses thereof

#14
20170247376
2017-08-31

Methods and compositions for inhibition of Ras

#15
20170051254
2017-02-23

Compositions comprising a mitofusin inhibitor for promoting cell reprogramming and a use thereof

#16
20160032264
2016-02-04

Preparations and methods for treating malignancies

#17
20160008448
2016-01-14

RHOC-BASED IMMUNOTHERAPY

#18
20150273026
2015-10-01

Clinical Applications for Recombinant Human MxA Protein

#19
20150202269
2015-07-23

AAV-mediated gene therapy for RPGR X-linked retinal degeneration

#20
20150098938
2015-04-09

Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof

#21
20110002954
2011-01-06

RhoC-based immunotherapy